DAYLINE
LIVE

Serial Number

79394151

Owner

Bausch Health Ireland Limited

Attorney

Jeremy Blackowicz

Filing Date

Jan 4, 2024

Add to watchlist:

No watchlists yet
View on USPTO

DAYLINE Trademark

Serial Number: 79394151 • Registration: 7574989

DAYLINE is a trademark filed by Bausch Health Ireland Limited on January 4, 2024. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Bausch Health Ireland Limited

3013 Lake Drive Citywest Business Campus

Entity Type: 99

Trademark Details

Filing Date

January 4, 2024

Registration Date

November 26, 2024

Published for Opposition

September 24, 2024

Goods & Services

Providing medical and health information to consumers and healthcare professionals regarding pharmaceutical products; medical information services, namely, providing medical and healthcare information regarding prescription drugs and disease treatment; providing medical and health information to consumers and healthcare professionals regarding medical aesthetics treatments and procedures; providing medical and health information to consumers and healthcare professionals regarding dental treatment, dental hygiene, and oral health; providing information in the fields of health, and wellness; performing non-invasive cosmetic medical procedures; medical clinic services, namely, cosmetic and therapeutic skin and body care treatment; laser skin rejuvenation service; laser skin tightening service

Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for pharmaceutical products for others; testing of pharmaceuticals; providing medical and scientific research information on the field of pharmaceuticals and clinical trials; conducting early evaluations in the field of new pharmaceuticals; developments of pharmaceutical drug delivery systems; product research and development services for others in the field of beauty, wellness, and health care products

pharmaceutical products and medicines for human use for prevention and treatment of allergic, autoimmune, bronchial, bone, cancer, cardiovascular, central nervous system, dermatological, endocrine, gastrointestinal, genitourinary, gynecological, hematological, hepatological, immunological, infectious, inflammatory, mental, metabolic, musculoskeletal, nephrological, neurological, neuromuscular, oncological, ophthalmic, oral, pain, psychiatric, pulmonary, renal, respiratory, urological, and viral diseases and disorders; Pharmaceutical products and medicines for human use for colonoscopies and endoscopic procedures; medicated skin care preparations; medicated oral care preparations; nutritional supplements; dietetic supplements, namely, dietetic preparations adapted for medical purposes; vitamins

Surgical apparatus and instruments; medical apparatus for the delivery and release of pharmaceuticals, namely, drug delivery patches sold without medication, inhalers for medical use sold empty, intravenous bags sold empty for intravenous therapy, syringes; medical devices for non-surgical cosmetic skin treatments; lasers for the medical treatment of the face and skin; radiofrequency therapy apparatus for the medical and cosmetic treatment of the face and skin, in particular for contracting skin, smoothing fine lines and wrinkles on skin, body sculpting, and soft tissue reconstruction in a non-invasive manner; high frequency electromagnetic wave therapeutic instruments; liposuction apparatus; medical radiofrequency, laser, and ultrasound therapy apparatus for the treatment of cellulite; medical apparatus and instruments for body toning and body shaping

Non-medicated skin care preparations; non-medicated oral care preparations; non-medicated oral hygiene preparations, namely, toothpaste, mouthwash, dental rinse; cosmetics

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 10, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 24, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 24, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
May 17, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 24, 2025 FICS
FINAL DISPOSITION PROCESSED
Apr 24, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 26, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 26, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 26, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 24, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 4, 2024 NONP
REFUSAL PROCESSED BY IB
Aug 25, 2024 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 16, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 16, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 16, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 16, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 16, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 15, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 15, 2024 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 5, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 5, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 16, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jul 15, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 15, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
May 6, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 6, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 25, 2024 REPR